DigiMed Showcase: A New, High-Impact Track at Biotech Showcase

DigiMed Showcase is a high-visibility platform within Biotech Showcase, built to spotlight the full spectrum of technology-driven healthcare innovation—with a strong emphasis on MedTech, medical devices, digitally enabled care, and AI-powered drug discovery.

More than a presenting opportunity, DigiMed is a strategic stage to introduce and position your company’s vision, technology, and value proposition in front of an audience of decision-makers. From advanced devices and diagnostics to AI-driven drug discovery platforms and digital therapeutics, DigiMed brings together the companies redefining how we diagnose, treat, and manage disease—while enabling meaningful dialogue with the investors and partners shaping what comes next.

As the lines between MedTech, biopharma, and digital health continue to blur, this track creates a centralized destination for investors, pharma leaders, and strategic partners to discover scalable, investable innovation.

Core areas include MedTech and medical devices, digital health and therapeutics, AI and machine learning, drug discovery platforms, robotics, quantum computing, VR/AR, NLP and LLMs, brain-machine interfaces, bioprocessing, electroceuticals, and DNA/RNA synthesis.

LSW Members receive a $200 discount off registration fees with VIP code: supLSWA2027

In-person activities will unfold from January 11–13, 2027, at the Hilton San Francisco Union Square in San Francisco, California. Following this, the virtual components will take place during the subsequent week, from January 19–20, 2027, hosted on the partneringONE platform—an all-in-one digital experience that seamlessly combines both aspects of the event.